News
How does a sumatriptan 3-mg auto-injector on the market compare in terms of tolerability and efficacy to treat an episodic migraine attack compared to 6-mg formulations?
Dr. Reddy's Laboratories announced the launch of Sumatriptan Injection Autoinjector System for Subcutaneous Use, the generic version of GlaxoSmithKline's Imitrex STATdose Pen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback